Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer

Conradi, LC; Spitzner, M; Metzger, AL; Kisly, M; Middel, P; Bohnenberger, H; Gaedcke, J; Ghadimi, MB; Liersch, T; Ruschoff, J; Beissbarth, T; Konig, A; Grade, M

Grade, M (reprint author), Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Robert Koch Str 40, D-37075 Gottingen, Germany.

BMC CANCER, 2019; 19 (1):

Abstract

Background Abrogation of growth factor-dependent signaling represents an effective therapeutic strategy for patients with colorectal cancer (CRC). Her......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索